Development of PARP inhibitors in advanced prostate cancer
Bourlon, Maria Teresa, Valdez, Paola, Castro, Elena
Published in Therapeutic advances in medical oncology (01.01.2024)
Published in Therapeutic advances in medical oncology (01.01.2024)
Get full text
Journal Article
Genomic Landscape in Prostate Cancer in a Latin American Population
Angel, Martín, Freile, Berenice, Rodriguez, Andres, Cayol, Federico, Manneh Kopp, Ray, Rioja, Patricia, Soule, Tomas, Losco, Federico, Bernal Vaca, Laura, Penaloza, Jose Mauricio, Zapata Muñoz, Maycos Leandro, Neciosup, Silvia Patricia, Sanchez, Roger Rodrigo, Passarella, Carolina, Guerreño, Elvio, Farelluk, Diego, Maturana Leiva, Ernesto, Zarba, Martin, Bourlon, Maria Teresa, Mora Pineda, Mauricio, Sade, Juan Pablo
Published in JCO global oncology (01.09.2024)
Published in JCO global oncology (01.09.2024)
Get full text
Journal Article
Women with bladder cancer: an underserved population due to a faulty health care system or in a biological disadvantage?
Barragán-Carrillo, Regina, Remolina-Bonilla, Yuly Andrea, Caballero-Landinez, Rosa Elena, Bourlon de los Rios, Maria Teresa
Published in Revista Mexicana de Urología (20.01.2022)
Published in Revista Mexicana de Urología (20.01.2022)
Get full text
Journal Article
Endpoints reported in phase 3 randomized clinical trials at ASCO 2022
Teuwen, Laure-Anne Marie Nicole, Young, Joanna Alyse, Bourlon, Maria Teresa, Segelov, Eva, Prenen, Hans
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Racial differences in survival outcomes for early-stage (T1 tumor) penile cancer: Analysis from the Surveillance, Epidemiology, and End Results (SEER) database
Candelario, Nellowe, Molina, Elizabeth, Bourlon, Maria Teresa, Kim, Simon P., Kessler, Elizabeth R, Spiess, Philippe E., Flaig, Thomas W.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Global oncology authorship and access patterns
Bourlon, Maria Teresa, Jimenez, Brenda, Matar, Charbel Fadi, Gunn, Emilie M., Ginsburg, Ophira M., Lopes, Gilberto, Segelov, Eva
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Low-dose diethylstilbestrol (DES) as frontline treatment for hormone-sensitive metastatic prostate cancer (PC) in a low resource setting
Hinojosa, Juan, Pineda, Mauricio Mora, Gabilondo, Fernando, Bourlon, Maria Teresa
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Pharmacokinetics (PK), efficacy, and safety results from CheckMate 67T
George, Saby, Bourlon, Maria Teresa, Chacon, Matias Rodrigo, Cutuli, Hernan, Lopez Chuken, Yamil Alonso, Zurawski, Bogdan, Mota, Jose Mauricio, Magri, Ignacio, Burotto, Mauricio, Luz, Murilo, De Menezes, Juliana, Yanez Ruiz, Eduardo Patricio, Maruzzo, Marco, Bracarda, Sergio, Prusty, Subhransu, Rathod, Dhanrajsinh, Vezina, Heather, Yu, Zhuoxin, Zhao, Yue, Albiges, Laurence
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Results from 55-month follow-up of the CheckMate 9ER trial
Bourlon, Maria Teresa, Escudier, Bernard, Burotto, Mauricio, Powles, Thomas, Apolo, Andrea B., Shah, Amishi Yogesh, Porta, Camillo, Suárez, Cristina, Barrios, Carlos H., Richardet, Martin, Gurney, Howard, Kessler, Elizabeth R., Tomita, Yoshihiko, Bedke, Jens, Wang, Fong, Wang, Peter, Panzica, Julie, Fedorov, Viktor, Motzer, Robert J., Choueiri, Toni K.
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma
Chacon, Matias Rodrigo, Cutuli, Hernan J., Bracarda, Sergio, Maruzzo, Marco, Bourlon, Maria Teresa, Jacobs, Carmel, Pérez-Valderrama, Begoña, Magri, Ignacio, Richardet, Martin, Centkowski, Piotr, Fu, Simon Yuen Fai, Gurman, Pablo, Konduri, Srivani, Yu, Zhuoxin, Vezina, Heather, George, Saby, Albiges, Laurence
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Association between depth of response (DepOR) and clinical outcomes: Exploratory analysis in patients with previously untreated advanced renal cell carcinoma (aRCC) in CheckMate 9ER
Suárez, Cristina, Choueiri, Toni K., Burotto, Mauricio, Powles, Thomas, Bourlon, Maria Teresa, Shah, Amishi Yogesh, Tomita, Yoshihiko, Bedke, Jens, Zhang, Joshua, Simsek, Burcin, Scheffold, Christian, Escudier, Bernard, Motzer, Robert J., Apolo, Andrea B.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Nivolumab plus cabozantinib vs sunitinib for first-line treatment of advanced renal cell carcinoma (aRCC): 3-year follow-up from the phase 3 CheckMate 9ER trial
Burotto, Mauricio, Powles, Thomas, Escudier, Bernard, Apolo, Andrea B., Bourlon, Maria Teresa, Shah, Amishi Yogesh, Suárez, Cristina, Porta, Camillo, Barrios, Carlos H., Richardet, Martin, Gurney, Howard, Kessler, Elizabeth R, Tomita, Yoshihiko, Bedke, Jens, George, Saby, Scheffold, Christian, Wang, Peter, Fedorov, Viktor, Motzer, Robert J., Choueiri, Toni K.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Efficacy outcomes of nivolumab + cabozantinib versus pembrolizumab + axitinib in patients with advanced renal cell carcinoma (aRCC): Matching-adjusted indirect comparison (MAIC)
McGregor, Bradley Alexander, Geynisman, Daniel M., Burotto, Mauricio, Porta, Camillo, Suarez Rodriguez, Cristina, Bourlon, Maria Teresa, Barata, Pedro C., Gulati, Shuchi, Stwalley, Brian, Del Tejo, Viviana, Du, Ella X., Wu, Aozhou, Chin, Andi, Betts, Keith A., Huo, Stephen, Choueiri, Toni K.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Fear of recurrence as a triage strategy to identify testicular cancer survivors in need of psychological interventions
De La Mora, Hector, López, Claudia, Jimenez, Brenda, Sánchez, Patricia, Bourlon, Christianne, Castillo, Jose Dionisio, Bourlon, Maria Teresa
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors
Rodríguez-Olivares, José Luis, González-Sánchez, Héctor Raúl, Beas-Lozano, Evelyn Lilian, Arteaga-Vázquez, Jazmin, Elaine T Lam Md, Bourlon, María T
Published in Oncology (Williston Park, N.Y.) (01.10.2024)
Published in Oncology (Williston Park, N.Y.) (01.10.2024)
Get full text
Journal Article
Final overall survival analysis and organ-specific target lesion assessments with two-year follow-up in CheckMate 9ER: Nivolumab plus cabozantinib versus sunitinib for patients with advanced renal cell carcinoma
Powles, Thomas, Choueiri, Toni K., Burotto, Mauricio, Escudier, Bernard, Bourlon, Maria Teresa, Shah, Amishi Yogesh, Suárez, Cristina, Hamzaj, Alketa, Porta, Camillo, Hocking, Christopher, Kessler, Elizabeth R, Gurney, Howard, Tomita, Yoshihiko, Bedke, Jens, Zhang, Joshua, Simsek, Burcin, Scheffold, Christian, Apolo, Andrea B., Motzer, Robert J.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Nivolumab plus cabozantinib (N+C) versus sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial
Apolo, Andrea B., Powles, Thomas, Burotto, Mauricio, Bourlon, Maria Teresa, Hsieh, James J, Basso, Umberto, Shah, Amishi Yogesh, Suarez, Cristina, Porta, Camillo, Barrios, Carlos H., Gurney, Howard, Kessler, Elizabeth R, Retz, Margitta, George, Saby, Escudier, Bernard, Zhang, Joshua, Simsek, Burcin, Scheffold, Christian, Motzer, Robert J., Choueiri, Toni K.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study
Monteiro, Fernando Sabino Marques, Fiala, Ondřej, Massari, Francesco, Myint, Zin W., Kopecky, Jindrich, Kucharz, Jakub, Büttner, Thomas, Grande, Enrique, Bourlon, Maria Teresa, Molina-Cerrillo, Javier, Pichler, Renate, Buchler, Tomas, Seront, Emmanuel, Ansari, Jawaher, Bamias, Aristotelis, Bhuva, Dipen, Vau, Nuno, Porta, Camillo, Fay, Andre Poisl, Santoni, Matteo
Published in Clinical genitourinary cancer (01.04.2024)
Published in Clinical genitourinary cancer (01.04.2024)
Get full text
Journal Article
Differences in the expression of PTP-1B phosphatase in prostate cancer (PC) patients with and without adverse pathologic features (APF)
Bourlon, Maria Teresa, Pineda, Mauricio Mora, Urbina Ramírez, Shaddai, Leon Rodriguez, Eucario, Atisha-Fregoso, Yemil, De Anda Gonzalez, Jazmin
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Sexual health and quality of life in testicular cancer survivors (TCS) in a third level hospital of a middle-income country
De La Mora, Hector, Hinojosa, Juan, Velazquez, Hugo Eduardo, Castillejos-Molina, Ricardo Alonso, Monjaras, Victor, Bourlon, Maria Teresa
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article